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Is There True Gender Difference of Irritable 
Bowel Syndrome in Asia?
TO THE EDITOR: Irritable bowel syndrome (IBS) is very com-
mon, although it is not a life-threatening condition. Although in 
Western countries, up to 20% of adults suffer from IBS, includ-
ing those who have not consulted physicians,
1 the prevalence in 
Eastern countries tends to be lower and ranges from 6.5% to 
10.1%.
2,3 It usually gives an impact on quality of life through 
clinical symptoms, consultation, excessive medical care or in-
directly by absenteeism from work or school.
The female predominance in IBS is prominent in Western 
countries with a female-to-male ratio of 2-2.5:1.
4,5 However, fe-
male predominance is less apparent in the general population, 
which suggests that women with IBS are more likely to seek 
healthcare for their symptoms.
4 However, some Asian studies fail 
to report significant gender differences in the prevalence of IBS.
6 
The symptom presentation, IBS subtypes, pathophysiological 
response and treatment response may offer some clues for the ob-
served gender difference in IBS. The female predominance is 
more apparent in the IBS with constipation compared to IBS 
with diarrhea and alternating pattern.
5 Although gender differ-
ences in colon transit, visceral hypersensitivity or brain-gut inter-
action have not been reported consistently, there were several 
conflicting reports according to the menstrual cycle or hormone 
replacement.
5,6
Interestingly, Makharia et al
7 reported a female preponder-
ance of IBS prevalence in India. The previous hospital-based IBS 
prevalence studies from India showed a male predominance re-
lated more with health seeking behaviors of men.
8,9 Makharia et 
al
7 explained that the observed female predominance could arise 
from the differences in the sex hormones. A recent systematic re-
view suggested that increased gastrointestinal symptoms in IBS 
were strongly associated with the effect of menstrual cycle, and it 
might be related with ovarian hormones on visceral hypersen-
sitivity.
10 However, it is still not clear whether the gender differ-
ence of IBS prevalence is truly related with physiologic difference 
or different consultation behaviors. Consultation behaviors are 
determined by many factors, such as disease severity, convenience 
of medicine access, emotional stress or socio-cultural background. 
However, the IBS definition by Rome II or III criteria is not 
comprehensive in Asia
3 and does not include the concept of com-
prehensive disease severity.
The merit of epidemiologic studies lies in that it is comprised 
of a wide range of data and the collection of large study pop-
ulation, however, methodological limitation, such as the quality of 
data and the potential bias should be considered. In addition, 
gender differences and the effect of female sex hormones have 
generally been understudied in IBS. However, it is important to 
determine whether there are true differences according to gender 
in IBS because these studies may potentially impact the under-
standing of IBS, including pathophysiology or treatment mo-
dalities.
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